EdgeRock Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
+582
New +$232K 0.05% 146
2024
Q1
– Sell
-293
Closed -$145K – 156
2023
Q4
$145K Buy
+293
New +$135K 0.11% 61
2022
Q4
– Sell
-244
Closed -$111K – 159
2022
Q3
$111K Buy
+244
New +$117K 0.06% 76

Other funds holding ELV

EdgeRock Capital's ELV Position: Q3 2026 in Review

EdgeRock Capital opened a new position in Elevance Health (ELV) in Q3 2026: 582 shares worth $226K. The stake represents 0.05% of the portfolio and ranks #146 among its holdings. This is a return to the name: EdgeRock Capital previously reported a position in ELV as recently as Q4 2023.

EdgeRock Capital first reported a position in ELV in Q3 2022 and has held it in 3 quarters since. 1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • EdgeRock Capital held 582 shares of Elevance Health worth $226K as of Q3 2026.
  • Elevance Health was a new EdgeRock Capital position in Q3 2026.
  • Elevance Health made up 0.05% of EdgeRock Capital's portfolio in Q3 2026, its #146 holding.
  • EdgeRock Capital first reported a position in Elevance Health in Q3 2022 and has held it in 3 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on EdgeRock Capital's 13F filing for Q3 2026, filed 3 Nov 2026.